Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Blood coagulation is a critical physiological process that prevents excessive bleeding when blood vessels are injured. It involves a complex cascade of enzymatic reactions and cellular interactions, ultimately leading to the formation of a stable fibrin clot that seals wounds and allows for tissue repair. The process is tightly regulated to ensure both effective hemostasis and prevention of unwanted clot formation.
Various, depending on the specific drug. Anticoagulants inhibit clotting factors, antiplatelet drugs inhibit platelet aggregation, and thrombolytics dissolve existing clots.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood Coagulation.